1. Home
  2. SRI vs CABA Comparison

SRI vs CABA Comparison

Compare SRI & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRI
  • CABA
  • Stock Information
  • Founded
  • SRI 1965
  • CABA 2017
  • Country
  • SRI United States
  • CABA United States
  • Employees
  • SRI N/A
  • CABA N/A
  • Industry
  • SRI Auto Parts:O.E.M.
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SRI Consumer Discretionary
  • CABA Health Care
  • Exchange
  • SRI Nasdaq
  • CABA Nasdaq
  • Market Cap
  • SRI 210.9M
  • CABA 200.3M
  • IPO Year
  • SRI 1997
  • CABA 2019
  • Fundamental
  • Price
  • SRI $6.81
  • CABA $2.36
  • Analyst Decision
  • SRI Buy
  • CABA Strong Buy
  • Analyst Count
  • SRI 1
  • CABA 8
  • Target Price
  • SRI $16.00
  • CABA $12.75
  • AVG Volume (30 Days)
  • SRI 186.5K
  • CABA 2.5M
  • Earning Date
  • SRI 10-29-2025
  • CABA 11-13-2025
  • Dividend Yield
  • SRI N/A
  • CABA N/A
  • EPS Growth
  • SRI N/A
  • CABA N/A
  • EPS
  • SRI N/A
  • CABA N/A
  • Revenue
  • SRI $877,921,000.00
  • CABA N/A
  • Revenue This Year
  • SRI N/A
  • CABA N/A
  • Revenue Next Year
  • SRI $7.68
  • CABA N/A
  • P/E Ratio
  • SRI N/A
  • CABA N/A
  • Revenue Growth
  • SRI N/A
  • CABA N/A
  • 52 Week Low
  • SRI $3.54
  • CABA $0.99
  • 52 Week High
  • SRI $10.33
  • CABA $5.46
  • Technical
  • Relative Strength Index (RSI)
  • SRI 29.52
  • CABA 61.71
  • Support Level
  • SRI $7.38
  • CABA $2.24
  • Resistance Level
  • SRI $7.72
  • CABA $2.59
  • Average True Range (ATR)
  • SRI 0.29
  • CABA 0.20
  • MACD
  • SRI -0.13
  • CABA 0.00
  • Stochastic Oscillator
  • SRI 1.98
  • CABA 66.28

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: